Organon (OGN) Cost of Revenue (2020 - 2026)

Organon has reported Cost of Revenue for 7 years, with the latest figure at $711.0 million in Q2 2026.

• Cost of Revenue for Q2 2026 came in at $711.0 million, down 1.25% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.9 billion (up 5.53% YoY), and the FY2025 annual result was $2.9 billion, up 8.0% from the prior year.
• Cost of Revenue improved to $711.0 million in Q2 2026, from $677.0 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $766.0 million in Q4 2025 and troughed at $551.0 million in Q3 2022.
• A 5-year average of $654.9 million and a median of $666.5 million in 2024 frame the typical range for Cost of Revenue.
• The widest annual swing landed in 2022, when Cost of Revenue fell 9.52%; it then gained 14.98% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $594.0 million in 2022, then rose by 14.98% to $683.0 million in 2023, then rose by 1.9% to $696.0 million in 2024, then rose by 10.06% to $766.0 million in 2025, then fell by 7.18% to $711.0 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $711.0 million in Q2 2026, $677.0 million in Q1 2026, and $766.0 million in Q4 2025.